Yael Annis

Title: Yael Annis: Innovator in Androgen-Dependent Disorder Treatments

Introduction

Yael Annis is a prominent inventor based in Hashmonaim, Israel. She has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. Her innovative work has led to the development of a unique patent that addresses these health issues.

Latest Patents

Yael Annis holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding the chimeric polypeptide and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia.

Career Highlights

Yael Annis has established herself as a key figure in her field through her innovative research and development efforts. She is associated with the Technion Research & Development Foundation Limited, where she continues to advance her work in medical science. Her dedication to improving treatments for androgen-dependent disorders has garnered attention and respect within the scientific community.

Collaborations

Yael Annis collaborates with talented individuals such as Roee Amit and Alexey Tomsov. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Yael Annis is a remarkable inventor whose work in treating androgen-dependent disorders has the potential to make a significant impact on healthcare. Her innovative patent and collaborations reflect her commitment to advancing medical science.